TECHNOLOGY

The use of new technology to enhance healthcare communications and data presentation is an exciting area. At Bluelight we have experience of developing and delivering augmented reality (AR), touchscreen, 3D and mobile technologies for healthcare communications to enhance data delivery, education and engagement.

 

Technology Articles

Autism Speaks: Kinect Powered Digital Billboards

Autism Speaks has created a Kinect powered digital billboard featuring a life size girl who avoids eye contact no matter how hard you try.  An interactive video screen using Kinect motion-sensors to raise awareness for Autism Speaks. The little girl avoids eye contact; one of the most prominent signs of the disorder in children. The [...]

Posted February 19th, 2012 by SamWalmsley & filed under Technology.

Are health apps medical devices? A white paper from Bluelight & D4

Health professionals make considerable use of mobile phones during their working day, as do their patients. As the popularity of running software applications on mobile devices continues to increase, we anticipate that the use of apps to aid medical diagnosis and treatment will continue to gain in popularity with a corresponding increase in risk to [...]

Posted January 10th, 2012 by SamWalmsley & filed under Compliance, Mobile, Technology, White Papers.

Should health apps be registered as medical devices? (Press Release)

How safe is that app? Should pharma apps be registered as medical devices? Written by Sam Walmsley and Paul Dixey at Bluelight Partners What impact does the first app to be registered as a medical device with the MHRA have upon pharmaceutical companies and the apps they produce? EMBARGO 8am 10th January 2012 10 January 2012, London – [...]

Posted January 10th, 2012 by SamWalmsley & filed under Compliance, Mobile, Technology.

How to develop and deliver engaging and compliant healthcare digital communications

It is now nearly one year since the PMCPA released Digital Guidelines to go alongside the ABPI Code of Practice. Despite much commentary and repeated requests by many in the pharmaceutical industry it is only the PMCPA in the UK and LIF, the trade association for the research-based pharmaceutical industry in Sweden, that have issued such guidance. It is now over 2 years since the FDA held hearings but have only in December 2011 issued draft guidelines limited to how to respond to unsolicited requests for information about off-label use.

Posted December 14th, 2011 by PaulDixey & filed under Compliance, Mobile, Social, Technology, Websites.

Augmented Reality in breast cancer awareness campaign

‘Hello Boobs’ campaign for breast cancer charity CoppaFeel! has launched a digital outdoor campaign in augmented reality with blippar. Using the blippar app to hold your phone towards the image, which will enable you to see the boobs in 3D, but also allow you to name them! The mission of the charity is to convey [...]

Posted December 13th, 2011 by SamWalmsley & filed under Technology.